Chinese biotech startup Lepu Biotech has raised an aggregate of 1.291 billion yuan ($186 million) in a Series B round co-led by Ping An Insurance (Group)’s investment vehicle Ping An Capital and Sunshine Insurance Group-backed private equity firm Riverhead Capital Investment Management.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
